Helen M Naylor, M.S.
- Phone:
- (615) 936-3744
- Email:
- helen.naylor@vumc.org
- Office:
- 3401 West End Ave., Suite 304 M
Job Related Information
Job Title:
- Senior Information Scientist and Associate Director for Precision Medicine Services
Department:
Center for Knowledge Management
Area(s) of Responsibility:
- Filtering/Evidence-Based Services
- Precision Medicine research and training
- Translation of Medical and Genetic information for patients
- Genetic and Health literacy
- Knowledge Management
- Education Services
- Staff Training
Learning Framework Skills:
Published Works:
- Huang JK, Wen L, Swegle M, Tran HC, Thin TH, Naylor HM, et al. Nucleotide sequence of a rice genomic clone that encodes a class I endochitinase. Plant molecular biology. 1991;16(3):479-80. Epub 1991/03/01. [Full-text in PubMed PMID: 1893114]
- Naylor HM, Newcomer ME. The structure of human retinol-binding protein (RBP) with its carrier protein transthyretin reveals an interaction with the carboxy terminus of RBP. Biochemistry. 1999;38(9):2647-53. Epub 1999/03/03. [Full-text in PubMed PMID: 10052934]
- Giuse NB, Kusnoor SV, Koonce TY, Ryland CR, Walden RR, Naylor HM, et al. Strategically aligning a mandala of competencies to advance a transformative vision. Journal of the Medical Library Association: JMLA. 2013;101(4):261. [Full-text in PubMed PMID: 24163597]
- Choma DP, Vanacore R, Naylor H, Zimmerman IA, Pavlichenko A, Pavlichenko A, et al. Aquaporin 11 Variant Associates with Kidney Disease in Type 2 Diabetic Patients. American journal of physiology Renal physiology. 2015:ajprenal 00295 2015. [Full-text in PubMed PMID: 26719361]
- Giuse NB, Kusnoor SV, Koonce TY, Naylor HM, Chen SC, Blasingame MN, et al. Guiding Oncology Patients Through the Maze of Precision Medicine. Journal of health communication. 2016;21 Suppl:5-17. [Full-text in PubMed PMID: 27043753]
- Pulley, JM, Jerome, RN, Zaleski, NM, Shirey-Rice, JK, Pruijssers, AJ, Lavieri, RR, Chettiar, SN, Naylor, HN, Arnoff, DM, Edwards, DA, Niswender, CM, Dugan, LL, Crofford, LJ, Bernard, GR Holroyd, KJ. When Enough is Enough: Decision Criteria for Moving a Known Drug Into Clinical Testing for a New Indication in the Absence of Preclinical Efficacy Data. Assay Drug Dev Technol. 2017 Dec;15(8):354-361. [Full-text in PubMed PMID: 29193979]
- Pulley JM, Jerome RN, Shirey-Rice JK, Zaleski NM, Naylor HM, Pruijssers AJ, Jackson JC, Bernard GR, Holroyd KJ. Advocating for mutually beneficial access to shelved compounds. Future Med Chem. 2018 Jun 1;10(12):1395-1398. doi:10.4155/fmc-2018-0090. Epub 2018 May 23. PubMed PMID: 29788759.